Eli Lilly Stock Split Rumors Gain Traction Amid Record High Share Price
Speculation mounts that Eli Lilly (LLY) may follow Netflix's lead with a potential stock split as its shares hover NEAR all-time highs. The pharmaceutical giant's stock last split in 1997—a 26-year gap that analysts argue warrants fresh division given its $1,054 price tag and $1 trillion market cap.
While splits don't alter fundamental valuations, they democratize access for retail investors. LLY trades at 51x forward earnings—a premium valuation echoing the bull-market conditions that typically precipitate such corporate actions. Apple and other megacaps have recently executed similar maneuvers.